Table 2.
Patient outcomes of human cohort studies using ICG and MB. Only patients where visualization using fluorescence was attempted are included in the table
Article | Reference | Surgical specialism | Laparoscopic/open | Number of patients | Administration | Dose | Ureters identified | Complications | |
---|---|---|---|---|---|---|---|---|---|
Indocyanine green | Siddighi et al. (2014) | [14] | Gynaecologic | Laparoscopic | > 10 | Ureteral catheter | 25 mg in 10 mL/ureter | All | None |
Lee et al. (2015) | [15] | Urologic | Laparoscopic | 25 | Ureteral catheter and/or PNT | 25 mg in 10 mL/ureter | All | Yes, in one patienta | |
Methylene blue | Verbeek et al. (2013) | [18] | Abdominal | Open | 12 | Intravenous | 0.25–1 mg/kg | 24/24 | None |
Yeung et al. (2016) | [19] | Colorectal | Both | 8 | Intravenous | 0.25–1 mg/kg | 10/11 | None | |
Al-Taher et al. (2016) | [20] | Colorectal | Laparoscopic | 9 | Intravenous | 0.125–1.0 mg/kg | 6/9 | None | |
Barnes et al. (2018) | [21] | Colorectal | Both | 40 | Intravenous | 0.25–1 mg/kg | 63/69 | None |
NT percutaneous nephrostomy tube, ICG indocyanine green, MB methylene blue
aOrgan laceration due to trocar placement during uretero-ureterostomy